Citadel Advisors’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $107M | Sell |
490,285
-243,066
| -33% | -$53.9M | 0.02% | 768 |
|
|
2025
Q4 | $168M | Sell |
733,351
-2,372,075
| -76% | -$540M | 0.03% | 568 |
|
|
2025
Q3 | $719M | Sell |
3,105,426
-147,435
| -5% | -$30M | 0.11% | 115 |
|
|
2025
Q2 | $604M | Buy |
3,252,861
+1,405,899
| +76% | +$261M | 0.1% | 132 |
|
|
2025
Q1 | $387M | Buy |
1,846,962
+1,128,425
| +157% | +$219M | 0.07% | 193 |
|
|
2024
Q4 | $128M | Buy |
718,537
+471,342
| +191% | +$86.7M | 0.02% | 606 |
|
|
2024
Q3 | $48.8M | Buy |
+247,195
| New | +$46.1M | 0.01% | 1237 |
|
|
2024
Q2 | – | Sell |
-5,968
| Closed | -$989K | – | 14132 |
|
|
2024
Q1 | $1.09M | Sell |
5,968
-523,426
| -99% | -$90.2M | ﹤0.01% | 6750 |
|
|
2023
Q4 | $82M | Sell |
529,394
-2,596,834
| -83% | -$379M | 0.02% | 811 |
|
|
2023
Q3 | $466M | Buy |
3,126,228
+1,195,188
| +62% | +$175M | 0.1% | 109 |
|
|
2023
Q2 | $260M | Sell |
1,931,040
-333,303
| -15% | -$48.9M | 0.05% | 231 |
|
|
2023
Q1 | $361M | Buy |
2,264,343
+1,785,323
| +373% | +$273M | 0.08% | 154 |
|
|
2022
Q4 | $77.4M | Sell |
479,020
-43,650
| -8% | -$6.69M | 0.02% | 799 |
|
|
2022
Q3 | $70.1M | Sell |
522,670
-39,540
| -7% | -$5.67M | 0.02% | 811 |
|
|
2022
Q2 | $86.1M | Sell |
562,210
-412,681
| -42% | -$63.1M | 0.02% | 656 |
|
|
2022
Q1 | $158M | Sell |
974,891
-4,831
| -0.5% | -$702K | 0.03% | 446 |
|
|
2021
Q4 | $133M | Sell |
979,722
-148,952
| -13% | -$17.6M | 0.03% | 515 |
|
|
2021
Q3 | $122M | Buy |
1,128,674
+958,531
| +563% | +$110M | 0.03% | 566 |
|
|
2021
Q2 | $19.2M | Sell |
170,143
-964,097
| -85% | -$109M | ﹤0.01% | 2144 |
|
|
2021
Q1 | $123M | Sell |
1,134,240
-131,697
| -10% | -$14.1M | 0.03% | 493 |
|
|
2020
Q4 | $136M | Buy |
1,265,937
+786,013
| +164% | +$75.5M | 0.04% | 409 |
|
|
2020
Q3 | $42M | Sell |
479,924
-2,952,488
| -86% | -$278M | 0.01% | 982 |
|
|
2020
Q2 | $337M | Sell |
3,432,412
-1,804,079
| -34% | -$159M | 0.12% | 85 |
|
|
2020
Q1 | $399M | Buy |
5,236,491
+2,485,870
| +90% | +$212M | 0.18% | 53 |
|
|
2019
Q4 | $244M | Buy |
2,750,621
+2,378,946
| +640% | +$197M | 0.11% | 133 |
|
|
2019
Q3 | $28.1M | Sell |
371,675
-2,081,158
| -85% | -$143M | 0.01% | 1178 |
|
|
2019
Q2 | $178M | Buy |
2,452,833
+1,810,774
| +282% | +$142M | 0.08% | 196 |
|
|
2019
Q1 | $51.7M | Buy |
642,059
+622,319
| +3,153% | +$50.9M | 0.03% | 672 |
|
|
2018
Q4 | $1.82M | Sell |
19,740
-1,519,899
| -99% | -$134M | ﹤0.01% | 4289 |
|
|
2018
Q3 | $146M | Sell |
1,539,639
-187,012
| -11% | -$17.7M | 0.06% | 273 |
|
|
2018
Q2 | $160M | Buy |
1,726,651
+1,345,279
| +353% | +$131M | 0.08% | 217 |
|
|
2018
Q1 | $36.1M | Buy |
381,372
+79,718
| +26% | +$8.76M | 0.02% | 760 |
|
|
2017
Q4 | $29.2M | Buy |
301,654
+135,766
| +82% | +$12.8M | 0.02% | 927 |
|
|
2017
Q3 | $14.7M | Sell |
165,888
-3,504,417
| -95% | -$267M | 0.01% | 1282 |
|
|
2017
Q2 | $266M | Buy |
3,670,305
+1,005,851
| +38% | +$67.6M | 0.23% | 52 |
|
|
2017
Q1 | $174M | Buy |
2,664,454
+2,190,409
| +462% | +$138M | 0.16% | 90 |
|
|
2016
Q4 | $29.7M | Sell |
474,045
-28,206
| -6% | -$1.72M | 0.03% | 628 |
|
|
2016
Q3 | $31.7M | Sell |
502,251
-29,138
| -5% | -$1.89M | 0.03% | 614 |
|
|
2016
Q2 | $32.9M | Sell |
531,389
-190,872
| -26% | -$11.6M | 0.04% | 518 |
|
|
2016
Q1 | $41.3M | Buy |
722,261
+613,290
| +563% | +$34.2M | 0.05% | 374 |
|
|
2015
Q4 | $6.46M | Sell |
108,971
-186,615
| -63% | -$10.7M | 0.01% | 1599 |
|
|
2015
Q3 | $16.1M | Buy |
295,586
+199,957
| +209% | +$13M | 0.02% | 1031 |
|
|
2015
Q2 | $6.42M | Sell |
95,629
-506,805
| -84% | -$33.1M | 0.01% | 1831 |
|
|
2015
Q1 | $35.3M | Buy |
602,434
+160,187
| +36% | +$9.68M | 0.03% | 654 |
|
|
2014
Q4 | $28.9M | Sell |
442,247
-373,527
| -46% | -$23.5M | 0.03% | 745 |
|
|
2014
Q3 | $47.1M | Buy |
815,774
+533,331
| +189% | +$29.6M | 0.05% | 444 |
|
|
2014
Q2 | $15.9M | Sell |
282,443
-240,610
| -46% | -$12.6M | 0.02% | 955 |
|
|
2014
Q1 | $26.9M | Buy |
523,053
+69,479
| +15% | +$3.51M | 0.03% | 662 |
|
|
2013
Q4 | $24M | Buy |
453,574
+423,161
| +1,391% | +$20.8M | 0.03% | 705 |
|
|
2013
Q3 | $1.36M | Sell |
30,413
-982
| -3% | -$43.5K | ﹤0.01% | 2785 |
|
|
2013
Q2 | $1.3M | Buy |
+31,395
| New | +$1.37M | ﹤0.01% | 2927 |
|
Other funds holding ABBV
VCM
VPM
Citadel Advisors's ABBV Position: Q1 2026 in Review
Citadel Advisors reduced its AbbVie (ABBV) stake by 33% in Q1 2026, selling an estimated $53.9M and leaving 490,285 shares worth $107M. The position accounts for 0.02% of the portfolio, ranked #768.
Citadel Advisors first reported a position in ABBV in Q2 2013 and has held it in 51 quarters since. The position peaked at $719M in Q3 2025. 4,076 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.
- Citadel Advisors held 490,285 shares of AbbVie worth $107M as of Q1 2026.
- Citadel Advisors sold 243,066 AbbVie shares in Q1 2026, an estimated $53.9M.
- AbbVie made up 0.02% of Citadel Advisors's portfolio in Q1 2026, its #768 holding.
- Citadel Advisors first reported a position in AbbVie in Q2 2013 and has held it in 51 quarters since.
- Citadel Advisors's AbbVie position peaked at $719M in Q3 2025.
- 4,076 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.
Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.